Background Clinical course of pleuroparenchymal fibroelastosis (PPFE) shows
considerable variation among patients, but there is no established prognostic prediction …

Phase angle (PhA) represents a raw variable measured with bioelectrical impedance
analysis (BIA) that is used to assess malnutrition in many diseases, including respiratory …

Background The antifibrotic agent nintedanib has been reported to effectively prevent the
decline in forced vital capacity (FVC) in a broad range of interstitial lung diseases. However …

Background Idiopathic pleuroparenchymal fibroelastosis (iPPFE) is a rare interstitial lung
disease characterised by predominant upper-lobe fibrosis involving the pleura and …

Erector spinae muscle (ESM) size has been reported as a predictor of prognosis in patients
with some respiratory diseases. This study aimed to assess the association of ESM size on …

The identification of novel prognostic biomarkers might enhance individualized
management strategies in patients with idiopathic pulmonary fibrosis (IPF). Although several …

Objectives Sarcopenia is a syndrome characterized by reduced muscle mass and function. It
is well-recognized as a complication in chronic diseases such as chronic obstructive …

Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease often accompanied
by skeletal muscle wasting. We investigated whether skeletal muscle mass and muscle …

Background and objective PPFE is characterized by fibrosis in the pleura and subpleural
lung parenchyma in the upper lobes, while other types of ILD, mainly UIP, can be observed …

Rationale The pathophysiology of interstitial lung disease (ILD) impacts body composition,
whereby ILD severity is linked to lower lean mass. Objectives To determine i) if pectoralis …